The STAT guide to viral vectors, the linchpin of gene therapy

from $499.00

The STAT user’s guide to venture capital in biotech

from $995.00

STAT’s guide to interpreting clinical trial results

from $499.00

Biosimilars: What will it take to deliver on their promise?

from $499.00

The 20 Executives — and Companies — to Know in Chinese Biotech

from $499.00

Company License: The STAT user’s guide to venture capital in biotech

$1,696.00